Summary Data from the Registry of Digestive tumours of the D6partement of Cote d'Or (France) were used to study the characteristics of gastrointestinal non-Hodgkin's lymphomas in the 1976-90 period. The mean annual age-standardized incidence rate was 0.94 per 100 000 for men, and 0.54 per 100 000 for women. Incidence varied little during the study period. Overall 5-year survival rate was 34.3 ± 5.6%.
Only two population-based series of gastrointestinal nonHodgkin's lymphomas (NHL) have been described (Otter et al, 1989a; D'Amore et al, 1994) . The 
MATERIALS AND METHODS Patients
A population-based cancer registry, limited to digestive tumours, exists on the resident population of the COte d'Or, Burgundy, France (473 651 inhabitants at the time of the 1982 census). This study covers the 78 cases of primary gastrointestinal NHL diagnosed during the first 15 years of the Registry, i.e. between January 1976 and December 1990. In the Registry, information is routinely collected from pathology laboratories, university hospitals, local hospitals, surgeons, gastroenterologists, general practitioners, Social Security offices, and monthly reviews of death certificates. For this study, a special inquiry addressed to all gastroenterologists and oncologists was conducted to ensure complete collection of the cases. All pathological samples of digestive cancers that had been classified as anaplastic were reviewed with immunohistochemical staining. This procedure permitted retrospective diagnosis of six gastric NHLs.
Primary gastrointestinal NHL was defined according to Lewin et al (1978) : it occurs in a patient presenting with digestive symptoms and in whom NHL is confined to, or is clearly predominant within, the digestive tract. Patients with a digestive site discovered during staging investigations of a NHL were excluded from the study. The mesenteric localizations were considered to be primary intestinal NHL in accordance with the literature (Otter et al, 1989a Weingrad et al, 1982 Dragosics et al, 1985) .
A population-based registry limited to haematopoietic malignancies was created in January 1980 (Carli et al, 1986 (Stansfeld et al, 1988; Rohatiner et al, 1994) . In addition, information on the exact pathological type according to the Kiel classification was obtained for 61 patients (78.2%). Stage was assigned using the Ann Arbor system modified for extranodal lymphomas, which recognizes four stages (Carbone et al, 1971 1975, 1982 and 1990 censuses. For the purpose of geographical comparisons, rates were standardized by the direct method using the World Standard Population (Segi and Kurihara, 1969) . To describe the trend in digestive NHL incidence, an exponential curve of the form y = a exp b' was fitted to the annual incidence 511 rates by means of a regression technique. This method allowed for a direct interpretation of the average annual per cent change. Relative survival was used to estimate net survival, which excludes deaths not related to the disease itself. Rates were calculated with the Esteve method (Esteve et al, 1990) , using the age and sex specific French mortality tables.
RESULTS
Incidence by sex, age and place of residence A total of 78 cases of gastrointestinal NHL were diagnosed during the 15 years of the study in 43 men and 35 women. Incidence and survival rates are presented in Table 1 . The overall age-standardized incidence rates were 0.94 per 100 000 and 0.54 per 100 000 with a male-female ratio of 1.74. Ages ranged between 7 and 87 years (mean = 63.2 ± 2.1 years). Age-specific incidence curves by sex are displayed in Figure 1 
Symptoms
Abdominal pain was the most common complaint of patients with gastrointestinal NHL (n = 33, 42.3%). Other features at presentation were acute digestive obstruction (12.8%), body-weight loss (12.8%), patent digestive tract-intestinal bleeding (11.5%), abdominal mass (7.7%) and anaemia (6.4% Digestive non-Hodgkin's lymphomas in population 513 types of low-or high-grade NHL corresponding to peripheral lymph node equivalents.
Survival
The 1-year crude survival rate was 55.6 ± 5.7% (± s.d.); 2-year and 5-year crude survival rates were, respectively, 48.7 ± 5.7% and 34.3 ± 5.6%. Corresponding figures for relative survival rates were 56.3 ± 6.0%, 50.9 ± 5.7% and 37.5 ± 7.0%. Five-year survival was slightly higher for gastric and rectal NHL. One of the patients with a mesenteric NHL died after 11 months and the other was still alive 57 months after diagnosis.
DISCUSSION
The epidemiological characteristics of gastrointestinal NHL that appear in this study are somewhat different from those previously reported. Incidence in our series was 1.5-2 times higher than has been estimated in the US by Heath et al (1982) from hospital series. However, this difference may be due to special care in uncovering cases, in the present study, with histological review of cases of undeterminate diagnosis. Hospital series may also underregister very old patients. Our incidence rates are also slightly higher than those reported by the Danish Lymphoma Study Group from Denmark (0.71 per 100 000 and + 0.48 per 100 000 for men and women respectively) (D'Amore et al, 1994) .
Gastrointestinal NHL cases represented more than 50% of extranodal NHL cases when we cross-checked the two registries that cover the Cote d'Or area. Our proportion was greater than was reported earlier from the Connecticut Tumor Registry, 44% (Zheng et al, 1992) ; or from the Danish population study , 30% (D'Amore et al, 1991); or the Dutch population study, 36% (Otter et al, 1989b ). If we consider digestive NHL among all NHL types, this proportion (17%) is also higher than the proportion from the Connecticut Tumor Registry (about 9%) (Zheng et al, 1992) . Again, the relatively high proportion in the present study may be partly due to a more active search for gastrointestinal NHLs.
No obvious time trend in the incidence of gastrointestinal NHL could be demonstrated in the C8te d'Or over the past 15 years, whereas a sharp trend, for all NHL types (Carli et al, 1986) and in particular for gastric NHL, had been indicated in reports of the Surveillance, Epidemiology and End Results (SEER) programme of the National Cancer Institute (Severson and Davis, 1990; Zheng et al, 1992) . The retrospective discovery of six cases over the first 7 years of our series leads us to suspect better recognition of this disease as the main reason for the reported trends. No time trend in incidence was observed in the only other study that has reported incidence rates of gastrointestinal NHL in a defined population (D'Amore et al, 1994) .
The observed male predominance is a well-known (unexplained) feature of gastrointestinal NHL, also found in other types (Cantor and Fraumeni, 1980) , with a sex ratio as high as 2.5 in some series (Elias, 1979 ). An excess of urban cases is usually reported in the literature (Devesa and Fears, 1992) . Such a difference was not observed in our series, possibly because of an increasingly large proportion of the rural population working in towns and thus potentially exposed to urban environmental factors. This is consistent with the observation that in the USA the urban-rural ratio is decreasing over time (Devesa and Fears, 1992) .
The combination of a digestive tract cancer registry and a registry of haematopoietic malignancies enabled us to estimate the importance of gastrointestinal NHL among other types of NHL as well as among other digestive malignancies. Although the stomach is the most common location of gastrointestinal NHL, with proportions as high as 80% in some hospital series (Lewin et al, 1978; Rambaud, 1983; Williamson et al, 1983; Aozasa et al, 1988; List et al, 1988; Gobbi et al, 1990) , NHL represents only 4% of all gastric malignancies, whereas it accounts for almost 20% of small bowel neoplasms. These data are only typical of those from western nonLatin European countries or from North America. The situation is likely to be quite different in Mediterranean countries with the problem of the alpha-chain disease that occurs in the small bowel (Galian et al, 1977) . This disease is very rare in Burgundy, a region of France that is at some distance from the Mediterranean, (only one case was observed in our series, in a North African patient).
High-and low-grade NHL types were equally distributed in our series, which is in agreement with other studies (Dworkin et al, 1982; Gobbi et al, 1990) . As for subtypes, the distribution of lowgrade NHL was similar to that of other series, the most common types being the lymphoplasmocytoid and the diffuse centroblastic-centrocytic forms (Lennert et al, 1975; Aozasa et al, 1988) . For high-grade NHL, the centroblastic type was twice as common as the immunoblastic type, whereas they are usually equally represented in extranodal or digestive NHL series (Dragosics et al, 1985; Carli et al, 1986) . According to the Isaacson classification, high-grade NHL seems twice as frequent as low-grade NHL, a feature that has already been observed in recent hospital series (Ruskone-Fourmestreaux et al, 1993) .
Hospital series usually provide rather high survival figures for gastrointestinal NHL . This populationbased series demonstrates that gastrointestinal NHL is a severe disease with an overall 5-year survival rate of only 34.3%. Relative survival reported here for the first time is not very different from crude survival. Better recognition of the disease and changes in chemotherapy protocols have not improved prognosis, which has not changed with time. However, for gastric NHL overall 5-year survival was 40.5%, whereas in the same population series it was only 12% for gastric carcinomas (Hillon et al, 1983) .
Gastrointestinal NHL has raised great interest among physicians over the recent decades. The present study gives an unbiased picture of its occurrence in a defined population.
